heart icon heart icon
Our Stories
Our Company
Follow Us
Explore more Johnson & Johnson sites:
Australia
A graphic of the flag of Australia
Argentina
A graphic of the flag of Argentina
Brazil
A graphic of the flag of Brazil
Canada
A graphic of the national flag of Canada
Chile
A graphic of the flag of Chile
China
A graphic of the national flag of the People's Republic of China
Colombia
A graphic of the national flag of Colombia
Costa Rica
A graphic of the national flag of Costa Rica
Czech Republic
Ecuador
A graphic of the national flag of Ecuador
Germany
A graphic of the flag of Germany
India
A graphic of the national flag of India
Japan
A graphic of the national flag of Japan
Mexico
A graphic of the flag of Mexico
New Zealand / Pacific
A graphic of the flag of New Zealand
Paraguay
A graphic of the flag of Paraguay
Peru
A graphic of the flag of Peru
Philippines
A graphic of the national flag of the Philippines
Russia
A graphic of the flag of Russia
Switzerland
A graphic of the flag of Switzerland
German
English
French
United States
A graphic of the flag of the United States of America
Uruguay
A graphic of the national flag of Uruguay
Venezuela
A graphic of the flag of Venezuela
Share

Investor Information

Latest News Releases

Our Company
January 15, 2021
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
Our Company
December 18, 2020
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
Our Company
December 14, 2020
Johnson & Johnson to Participate in the 39th Annual J.P. Morgan Healthcare Conference
See All News Releases
Johnson & Johnson To Appeal Flawed Opioid Judgment in Oklahoma
Johnson & Johnson To Appeal Flawed Opioid Judgment in Oklahoma
ON NOW A sign at Johnson & Johnson World Headquarters in New Brunswick, NJ
Webcast: Pharm Business Review 2019
Webcast: Pharm Business Review 2019
ON NOW A photo of the Johnson & Johnson museum exterior at its world headquarters in New Jersey
Webcast: Health for Humanity Report
Webcast: Health for Humanity Report
ON NOW
Statement on Reuters Talc Article
Statement on Reuters Talc Article
Johnson & Johnson issued the following statement regarding speculation about the safety of our products.
ON NOW Johnson and Johnson Credo Wall

Investor Relations

Investor FAQs
Answers to common questions regarding purchasing and owning Johnson & Johnson stock.
Learn More
2019 Health for Humanity Report
We blend heart, science and ingenuity to profoundly change the trajectory of health for humanity.
Learn More
Contact Investor Relations
Questions? Please contact Investor Relations:
This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.